3D Lab (Drug Discovery and Development Lab) is a pioneering research group at the University of Chittagong, dedicated to transforming Bangladesh’s presence in global drug innovation. Founded by a researcher trained at King’s College London, the lab bridges the gap between world-class research and the resource-constrained academic environment of public universities.
We work at the intersection of medicinal chemistry, molecular epidemiology, and genomic science to uncover novel therapeutic targets and support the development of new drugs. Our goal is to enable home-grown innovation in a country where over 300 pharmaceutical companies manufacture medicines, but none have yet discovered a drug of their own.
In our lab, we support medicinal chemists by conducting mechanistic drug studies, such as MIC testing, mode-of-action analysis, and genotype-informed responses, to help push promising compounds closer to clinical application. We also study the genetic basis and population dynamics of systemic diseases like obesity and diabetes, seeking to uncover druggable genomic targets relevant to local and regional populations.
More than a research lab, 3D Lab is a training ground for under-resourced but highly talented students, many of whom are the first in their families to attend university. We provide access to research tools, international skills, and scientific mentorship, empowering students to rise beyond boundaries and contribute meaningfully to science, society, and country.
We are not just discovering drugs—we are Innovating Cure.
Our journey to the 3D lab
Master’s Degree Completion
Dr. Hasan completed a Master’s in Genetic Engineering and Biotechnology at Shahjalal University of Science and Technology, providing essential knowledge and skills for a career in biotechnology and microbiology.
Joined Pharmaceutical Industry
He began working as an R&D Officer at Incepta Pharmaceuticals Ltd, acquiring practical experience in biosimilar production and advanced techniques like mass spectrometry, crucial for future drug discovery efforts.
Dr Hasan Joined as a Lecturer
Appointed as a Lecturer in the Department of Genetic Engineering and Biotechnology at the University of Chittagong, marking the transition to academia and enabling research leadership opportunities.
Promotion to Assistant Professor
Dr. Hasan was promoted to Assistant Professor at the Department of Genetic Engineering & Biotechnology, CU.
PhD Studies Commenced
He started a PhD in cancer drug discovery at King’s College London as a Commonwealth Scholar, deepening his expertise in medicinal chemistry and antibody-drug conjugates essential for leading advanced research.
PhD Degree Awarded
He completed his PhD with groundbreaking work on anticancer payloads, resulting in patented compounds and enhancing his credentials to lead the 3D Lab in innovative drug development research.
Promotion to Associate Professor
Dr. Hasan was promoted to Associate Professor at the University of Chittagong on 01 August 2025.
3D Lab Leadership
Dr. Hasan began developing the Drug Discovery and Development Lab (3D Lab) at CU to integrate synthetic chemistry, microbiology, and cell biology for cancer and AMR research.
Academic Editor Role
Dr. Hasan Appointed Academic Editor of PLOS ONE on 15 August 2025.